Skip to content
AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium episode artwork

EPISODE · Mar 30, 2026 · 1H 29M

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

from Oncology Today with Dr Neil Love

Prof Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT inhibition in prostate cancer. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Mar 30, 2026

Embed this episode

Ready to play

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

0:00 1:29:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 1 hour and 29 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on March 30, 2026.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!